Here are JPMorgan's top drug stock picks into earnings

Bottles of Eli Lilly's Cymbalta on a pharmacy shelf in Princeton, Illinois.
Daniel Acker | Bloomberg | Getty Images

JPMorgan's research team named its favorite pharmaceutical picks ahead of second quarter earnings releases.

Given recent rotation back into the sector, JPMorgan analysts "wanted to share our latest thoughts on key incoming questions for our Speciality & Major Pharma coverage," they wrote on Wednesday.

Here are three companies that JPMorgan recommended.

More In Pro News and Analysis

CNBC ProChina's Gen Z are set to spend big – analysts pick 3 stocks that could be winners
CNBC ProUBS: These stocks are ‘best positioned’ to benefit as the chip shortage drags on
CNBC ProBlackRock's Rick Rieder says the Fed should send signal that it will step back from easy policies